跳至主要内容
临床试验/NCT05050110
NCT05050110进行中(未招募)不适用

Evaluation of Increased Fruits and Vegetables Consumption in Chronic Kidney Disease Patients Maintaining Normokalemia With Patiromer

Nand Wadhwa2 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2020年11月24日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
13
试验地点
2
主要终点
By increasing the consumption of Fruits and Vegetable in their daily diet using the Nutritional Fruits and Vegetable Diary based off of the USDA Nutritive Value of foods and completing the Quality of Life Nutritional Questionnaire.

研究概览

简要总结

This study aims to investigate the feasibility of increasing dietary consumption of a rich variety of fruits and vegetables (including those that are potassim-rich) in patients with chronic kidney disease through use of nutritional counselling and hyperkalemia management with patiromer

详细描述

Adult Patients ages 18 and older with a diagnosis of Chronic Kidney Disease will be given a Diet Plan that consist of an increase of Fruits and Vegetables. Baseline data will be collected after the subject has signed the consent and their most recent eGFR and potassium level that is within 90 days has been reviewed to determine they are within the inclusion criteria.

Based on the approved Patiromer (Veltassa) package insert the subject will begin to take daily. During this control period of two weeks, the subject will document their normal daily consumption of fruits and vegetables in a provided food diary.

On the Second week, patient will receive dietary/nutritional counseling on the importance of potassium-rich fruits and vegetables. They will be instructed to increase their fruit and vegetable intake based on personal preferences and nutritional guides located inside the food diary. Choices will be documented daily in the supplied food diaries.

The Bowel Diary will be classified according to the Bristol Stool Chart and Quality of Life. Nutrition Survey Questionnaire will be documented in that supplied log.

At each subsequent visit, food diaries will be reviewed to evaluate fruit and vegetable consumption, vital signs will be documented and labs collected to measure effects on potassium metabolism. Bowel habits and questionnaires will be completed by the subject to determine how their diet has affected their quality of life.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients ≥ 18 years of age with chronic kidney disease and hyperkalemia
  • Chronic kidney disease is defined as eGFR 15-44ml/min/1.73m2
  • Documented hyperkalemia which is defined as serum potassium ≥ 5.0 mmol/L during the last 90 days
  • Diet evaluation for hyperkalemia (serum potassium ≥ 5.0) during the last 90 days
  • Patients receiving RASS inhibitors, beta-blockers, or diuretics to be on stable doses for 2 weeks
  • Patients already receiving patiromer are eligible

排除标准

  • Patients with a known allergy to patiromer
  • Patients currently taking other potassium controlling agents.

结局指标

主要结局

By increasing the consumption of Fruits and Vegetable in their daily diet using the Nutritional Fruits and Vegetable Diary based off of the USDA Nutritive Value of foods and completing the Quality of Life Nutritional Questionnaire.

时间窗: 3 years

Participants will increase the Fruit and vegetable consumption by following a Diet plan listed in the Nutritional Diary provided to them by the study site in the beginning of the study while taking Patiromer (Veltassa). This will record their daily intake of 26-28 servings of fruit and vegetables weekly. The Nutritional diary lists a Diet Plan that measures the serving size of 26-28 servings of the fruits and vegetables. The measurement of fruits and vegetables has been calculated by the Nutritionist based off of the USDA Nutritive Value of foods and listed on the diary to explain the serving sizes and suggestions of meal plans.

次要结局

  • The Kidney Function levels will be tested at each visit from blood samples provided by the subject.(3 years)

研究者

发起方
Nand Wadhwa
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Nand Wadhwa

Nephrologist, Principal Investigator

NY Health d/b/a New York Cancer and Blood Specialists

研究点 (2)

Loading locations...

相似试验